M&G Investment Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

M&G Investment Management’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-12,105	Closed	-$242	–	794
2021 Q3	$242	Sell	12,105 -22,491	-65%	-$621K	﹤0.01%	716
2021 Q2	$1.28K	Buy	+34,596	New	+$1.06M	﹤0.01%	593

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

M&G Investment Management's DRNA Position: Q4 2021 in Review

M&G Investment Management sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 12,105 shares — an estimated $242 sold.

M&G Investment Management first reported a position in DRNA in Q2 2021 and held it in 2 quarters. The position peaked at $1.28K in Q2 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

M&G Investment Management reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
M&G Investment Management sold 12,105 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $242.
M&G Investment Management first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2021 and held it in 2 quarters.
M&G Investment Management's Dicerna Pharmaceuticals, Inc. position peaked at $1.28K in Q2 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.